AB242-AA3,2,7
3“49.162
(4) (b) During the time that an individual
or group member is receiving
4substance abuse treatment under par. (a), the administering agency shall require
5the individual
or group member to undergo random testing for the use of a controlled
6substance.
For Except as provided in sub. (4m), for the individual to remain eligible
7for a program, the individual
or his or her group member must cooperate with the
8testing
and the results of the tests must be negative or, if any results are positive, the
9individual must present evidence of a valid prescription as described in sub. (3). If
10the results of any test during treatment are positive for the use of a controlled
11substance and the individual
or group member does not present evidence of a valid
12prescription for the controlled substance, the individual
shall have the opportunity
13to begin the treatment again one time, as determined by the administering agency.
1If the individual begins the substance abuse treatment again, he or she shall remain
2eligible for a program as long as the results of all tests for the use of a controlled
3substance during the subsequent treatment are negative for the use of a controlled
4substance or, if any results are positive, the individual presents evidence of a valid
5prescription for the controlled substance remains eligible for a program as long as
6the individual or group member continues in the substance abuse treatment under
7par. (a).”.